Indefinite Delivery Contract SPE2DB20D2104

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a total ceiling value of $999,999,999. The contract serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC covers an extensive array of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains such as cardiovascular health, diabetes management, mental health treatments, pain management, and infectious disease prevention.

The task orders awarded under this IDC demonstrate the breadth of products being delivered, including medications like Viberzi, Trulicity, Cosentyx, Benlysta, Januvia, and Xeljanz, as well as medical devices, diagnostic products, and other healthcare-related items. The contract has a period of performance running through November 2026 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation covering similar medical products and prescription drugs, further showcasing its role as a critical supplier to various federal government agencies and healthcare programs.